神经退行性疾病：从分子基础到治疗。
Neurodegenerative Disease: From Molecular Basis to Therapy.
机构信息
Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.
出版信息
Int J Mol Sci. 2024 Jan 12;25(2):967. doi: 10.3390/ijms25020967.
Abstract
Neurodegenerative diseases are a heterogeneous group of age-related disorders characterised by the progressive degeneration or death of neurons in the central or peripheral nervous system [...].
摘要
神经退行性疾病是一组异质性的与年龄相关的疾病，其特征是中枢或外周神经系统中的神经元进行性退化或死亡[...]。
相似文献
1
Neurodegenerative Disease: From Molecular Basis to Therapy.
Int J Mol Sci. 2024 Jan 12;25(2):967. doi: 10.3390/ijms25020967.
2
Neurodegenerative Diseases: Molecular Mechanisms and Therapies.
Int J Mol Sci. 2023 Sep 6;24(18):13721. doi: 10.3390/ijms241813721.
3
Gene transfer into the central and peripheral nervous system: applications for the treatment of neurodegenerative diseases and peripheral neuropathies.
Biotechnol Genet Eng Rev. 2003;20:49-76. doi: 10.1080/02648725.2003.10648037.
4
Neurodegenerative Diseases: From Molecular Basis to Therapy.
Int J Mol Sci. 2022 Oct 25;23(21):12854. doi: 10.3390/ijms232112854.
5
Study on Genotypes and Phenotypes of Neurodegenerative Diseases.
Genes (Basel). 2024 Jun 14;15(6):786. doi: 10.3390/genes15060786.
6
Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review.
Lab Anim Sci. 1999 Aug;49(4):358-62.
7
Adrenomedullin, a Novel Target for Neurodegenerative Diseases.
Mol Neurobiol. 2018 Dec;55(12):8799-8814. doi: 10.1007/s12035-018-1031-y. Epub 2018 Mar 29.
8
Advancing cell therapy for neurodegenerative diseases.
Cell Stem Cell. 2023 May 4;30(5):512-529. doi: 10.1016/j.stem.2023.03.017. Epub 2023 Apr 20.
9
[Gene and gene cellular therapy and neurodegenerative diseases].
Vopr Med Khim. 2000 May-Jun;46(3):311-23.
10
Potentials of ES cell therapy in neurodegenerative diseases.
Curr Pharm Des. 2008;14(36):3873-9. doi: 10.2174/138161208786898617.
引用本文的文献
1
Nerve growth factor: what can surgeons and oncologists learn from a neurological and psychological biomarker?
Mol Med. 2025 Aug 9;31(1):276. doi: 10.1186/s10020-025-01333-z.
2
Association of infection with the risk of neurodegenerative disorders: a systematic review and meta-analysis.
Front Med (Lausanne). 2025 Jul 4;12:1573299. doi: 10.3389/fmed.2025.1573299. eCollection 2025.
3
The rise of 3D bioprinting advancements in modeling neurodegenerative diseases.
Ibrain. 2025 Apr 22;11(2):259-267. doi: 10.1002/ibra.12196. eCollection 2025 Summer.
4
Mitochondrial quality control disorder in neurodegenerative disorders: Potential and advantages of traditional Chinese medicines.
J Pharm Anal. 2025 Apr;15(4):101146. doi: 10.1016/j.jpha.2024.101146. Epub 2024 Nov 14.
5
Multi-targeted benzylpiperidine-isatin hybrids: Design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies.
J Comput Aided Mol Des. 2025 Feb 28;39(1):10. doi: 10.1007/s10822-025-00588-2.
6
Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine.
Planta Med. 2025 Apr;91(5):226-237. doi: 10.1055/a-2512-8928. Epub 2025 Jan 8.
7
Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders - a review.
Int J Surg. 2024 Oct 1;110(10):6367-6381. doi: 10.1097/JS9.0000000000001609.
8
Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions.
Biomedicines. 2024 Sep 13;12(9):2096. doi: 10.3390/biomedicines12092096.
本文引用的文献
1
Amyloid Precursor Protein and Alzheimer's Disease.
Int J Mol Sci. 2023 Sep 30;24(19):14794. doi: 10.3390/ijms241914794.
2
Simufilam Reverses Aberrant Receptor Interactions of Filamin A in Alzheimer's Disease.
Int J Mol Sci. 2023 Sep 11;24(18):13927. doi: 10.3390/ijms241813927.
3
Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice.
Int J Mol Sci. 2023 Aug 22;24(17):13039. doi: 10.3390/ijms241713039.
4
The ε-Isozyme of Protein Kinase C (PKCε) Is Impaired in ALS Motor Cortex and Its Pulse Activation by Bryostatin-1 Produces Long Term Survival in Degenerating SOD1-G93A Motor Neuron-like Cells.
Int J Mol Sci. 2023 Aug 15;24(16):12825. doi: 10.3390/ijms241612825.
5
The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy.
Int J Mol Sci. 2023 Jul 31;24(15):12246. doi: 10.3390/ijms241512246.
6
α5-GABAA Receptor Modulation Reverses Behavioral and Neurophysiological Correlates of Psychosis in Rats with Ventral Hippocampal Alzheimer's Disease-like Pathology.
Int J Mol Sci. 2023 Jul 22;24(14):11788. doi: 10.3390/ijms241411788.
7
Vitamin E and Its Molecular Effects in Experimental Models of Neurodegenerative Diseases.
Int J Mol Sci. 2023 Jul 7;24(13):11191. doi: 10.3390/ijms241311191.
8
The QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer's Disease.
Int J Mol Sci. 2023 Jul 5;24(13):11119. doi: 10.3390/ijms241311119.
9
LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson's Disease Cell Model.
Int J Mol Sci. 2023 Jul 5;24(13):11111. doi: 10.3390/ijms241311111.
10
ARL6IP5 Ameliorates α-Synuclein Burden by Inducing Autophagy via Preventing Ubiquitination and Degradation of ATG12.
Int J Mol Sci. 2023 Jun 22;24(13):10499. doi: 10.3390/ijms241310499.
Zotero 插件